🇺🇸 FDA
Pipeline program

N-acetylcysteine

Pro00052757

Phase 2 small_molecule completed

Quick answer

N-acetylcysteine for Posttraumatic Stress Disorder (PTSD) is a Phase 2 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Posttraumatic Stress Disorder (PTSD)
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials